Clinical trial
Prevalence of Cytomegalovirus, Epstein Barr Virus and Human Herpes 6 Virus in…
NCT00222378 · University of Miami, Other · Completed
Key facts
| NCT number | NCT00222378 |
|---|---|
| Title | Prevalence of Cytomegalovirus, Epstein Barr Virus and Human Herpes 6 Virus in Inflammatory Bowel Disease |
| Official title | Prevalence of Cytomegalovirus, Epstein Barr Virus and Human Herpes 6 Virus DNA in Intestinal Mucosa of Patients With Inflammatory Bowel Disease |
| Lead sponsor | University of Miami, Other |
| Collaborators | Hoffmann-La Roche Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Crohn's Disease, Ulcerative Colitis |
| Enrollment | 129 |
| Start date | Apr 1, 2005 |
| Primary completion | Jun 1, 2012 |
| Completion | Jun 1, 2012 |
| First posted | Sep 22, 2005 |
| Last update posted | Jul 30, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: